Natriuretic Peptide Receptors in Human Artery and Vein and Rabbit Vein Graft
Authors:
- 1 March 1996
- journal article
- research article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 27 (3) , 833-837
Abstract
Abstract Natriuretic peptides elicit their biological effects by elevation of cGMP through activation of two biologically active receptors: natriuretic peptide A receptor, which shows high affinity to atrial and brain natriuretic peptides, and natriuretic peptide B receptor, which is specific to C-type natriuretic peptide. To elucidate the implications of the natriuretic peptide system in arteries and veins, we examined the cGMP production in response to atrial and C-type natriuretic peptides and gene expressions of biologically active natriuretic peptide receptors in human gastroepiploic artery, internal mammary artery, and saphenous vein. Atrial natriuretic peptide augmented cGMP production more potently by one order of magnitude in arteries than in veins. C-type natriuretic peptide stimulated cGMP production weakly and equally in these vessels. Analyzed by reverse transcription–polymerase chain reaction, gene expression of natriuretic peptide A receptor was four times more abundant in arteries than in veins. Gene expression of natriuretic peptide B receptor was approximately the same between these vessels. We also studied the responsiveness to atrial and C-type natriuretic peptide in rabbit jugular vein grafted into carotid artery. In arterialized vein grafts 4 weeks after operation, the effects of atrial and C-type natriuretic peptides on cGMP production did not change from those in jugular veins. In conclusion, atrial natriuretic peptide stimulates cGMP production more potently in arteries than in veins due to the preferential expression of natriuretic peptide A receptor in arteries. These observations support the distinct roles of natriuretic peptides in cardiovascular homeostasis.Keywords
This publication has 17 references indexed in Scilit:
- Detection of C-Type Natriuretic Peptide in Human Circulation and Marked Increase of Plasma CNP Level in Septic Shock PatientsBiochemical and Biophysical Research Communications, 1994
- Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-beta. Possible existence of "vascular natriuretic peptide system".Journal of Clinical Investigation, 1992
- Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide.Endocrinology, 1992
- C-TYPE NATRIURETIC PEPTIDE (CNP) IN RATS AND HUMANSEndocrinology, 1991
- Selective Activation of the B Natriuretic Peptide Receptor by C-Type Natriuretic Peptide (CNP)Science, 1991
- Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide.Journal of Clinical Investigation, 1991
- Differential activation by atrial and brain natriuretic peptides of two different receptor guanylate cyclasesNature, 1989
- A membrane form of guanylate cyclase is an atrial natriuretic peptide receptorNature, 1989
- Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: genomic complexity and molecular evolution of the geneNucleic Acids Research, 1985
- An ultrasensitive method for the simultaneous determination of cyclic AMP and cyclic GMP in small-volume samples from blood and tissueBiochemical Medicine, 1977